Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC ; volume:24 ; number:1 ; day:23 ; month:5 ; year:2024 ; pages:1-13 ; date:12.2024
BMC pulmonary medicine ; 24, Heft 1 (23.5.2024), 1-13, 12.2024
- Urheber
-
Mao, Zhirong
Pang, Guanchao
Huang, Xiaojie
Chen, Xiuxiu
Wu, Jiaji
Xu, Xia
Teng, Zhihua
Tan, Yanbin
Wang, Pingli
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-024-03041-6
- URN
-
urn:nbn:de:101:1-2408020950433.976798914066
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mao, Zhirong
- Pang, Guanchao
- Huang, Xiaojie
- Chen, Xiuxiu
- Wu, Jiaji
- Xu, Xia
- Teng, Zhihua
- Tan, Yanbin
- Wang, Pingli
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Checkpoint inhibitor pneumonitis: Short review of literature and case report
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Checkpoint inhibitor pneumonitis: Short review of literature and case report
Novel radiogenomics approach to predict and characterize pneumonitis in stage III NSCLC
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
Efficacy of neoadjuvant PD-1/PD-L1 inhibitor in resectable NSCLC: a meta-analysis based on randomized controlled trials
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis
Checkpoint inhibitor pneumonitis: Short review of literature and case report